Other products from "KANEKA PHARMA AMERICA LLC"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 04537693900639 KP-05 Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). PBN,MMY Apheresis For Focal Glomerulosclerosis In Pediatric Patients,Lipoprotein, Low De Apheresis For Focal Glomerulosclerosis In Pediatric Patients,Lipoprotein, Low Density, Removal 3 SULFLUX
2 18855036020688 NK-M3R(UL) Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of thre Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). PBN,MMY Apheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients,Lipoprote Apheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients,Lipoprotein, Low Density, Removal TUBING SYSTEM FOR PLASMAPHERESIS
3 04987671040374 KANEKA MA-03 Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOS Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). PBN,MMY Apheresis For Focal Glomerulosclerosis In Pediatric Patients,Lipoprotein, Low De Apheresis For Focal Glomerulosclerosis In Pediatric Patients,Lipoprotein, Low Density, Removal 3 APHERESIS MACHINE
Other products with the same Product Codes "PBN, MMY"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 18855036020688 NK-M3R(UL) Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of thre Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). TUBING SYSTEM FOR PLASMAPHERESIS KANEKA PHARMA AMERICA LLC
2 18855036020688 NK-M3R(UL) Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of thre Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). TUBING SYSTEM FOR PLASMAPHERESIS KANEKA PHARMA AMERICA LLC
3 18855036012850 NK-M3R(U) Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of thre Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). TUBING SYSTEM FOR PLASMAPHERESIS KANEKA PHARMA AMERICA LLC
4 18855036012850 NK-M3R(U) Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of thre Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). TUBING SYSTEM FOR PLASMAPHERESIS KANEKA PHARMA AMERICA LLC
5 14993478010110 LA-15 N/A Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performi Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). LIPOSORBER KANEKA CORPORATION
6 14993478010110 LA-15 N/A Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performi Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). LIPOSORBER KANEKA CORPORATION
7 04987671040374 KANEKA MA-03 Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOS Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). APHERESIS MACHINE KANEKA PHARMA AMERICA LLC
8 04987671040374 KANEKA MA-03 Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOS Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). APHERESIS MACHINE KANEKA PHARMA AMERICA LLC
9 04537693900639 KP-05 Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). SULFLUX KANEKA PHARMA AMERICA LLC
10 04537693900639 KP-05 Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS). SULFLUX KANEKA PHARMA AMERICA LLC
11 04046964699467 7061192 7061192 HELP HEPARIN 400,000 IU V 50/40ML US H.E.L.P.® B.BRAUN AVITUM AG
12 04046964696770 7211101 7211101 HELP ULTRAFILTER HIPS 20 US H.E.L.P.® B.BRAUN AVITUM AG
13 04046964695865 7211094 7211094 HELP HOT FUTURA SET US H.E.L.P.® B.BRAUN AVITUM AG
14 04046964337017 706210A 706210A The Plasmat® Futura System B.BRAUN B.BRAUN AVITUM AG
15 04046964319860 7061188 7061188 H.E.L.P. Heparin Sodium Solution 30 mL B.BRAUN B.BRAUN AVITUM AG
16 04046964290169 4113 4113 HELP ACETATE BUFFER 4.85 US 3000ML B.BRAUN B.BRAUN AVITUM AG
17 04046964290152 4109 4109 HELP BIC EL HCL US 5000ML B.BRAUN B.BRAUN AVITUM AG
18 04046964290145 4107 4107 HELP 0,9 % SODIUM CHLORIDE US 3000ML B.BRAUN B.BRAUN AVITUM AG
19 04046964290138 4103 4103 HELP 0,9 % SODIUM CHL. SET US 500/1500ML B.BRAUN B.BRAUN AVITUM AG
20 04046964249679 7210930 7210930 EMPTY BAGS FOR DIALYSATE FUTURA (US) B.BRAUN B.BRAUN AVITUM AG
21 04046964231834 7211089 7211089 HELP HEPARIN ADSORBER 400 US/CA B.BRAUN B.BRAUN AVITUM AG
22 04046964156731 4469 4469 H.E.L.P. ACETATPUFFER HOT US / CA H.E.L.P.® B.BRAUN AVITUM AG
23 04046964133534 7211091 7211091 HELP FUTURA SET WITH 4 FILTERS (US) B.BRAUN B.BRAUN AVITUM AG
24 04046963847418 7210934 7210934 EMPTY BAG CONNECTION LINE (US) B.BRAUN B.BRAUN AVITUM AG
25 04046963845797 7061007C 7061007C H.E.L.P. HEMOSELECT L 0,5 B.BRAUN B.BRAUN AVITUM AG
26 04046963845780 7210933 7210933 H.E.L.P. HEPARIN ADSORBER (US) B.BRAUN B.BRAUN AVITUM AG
27 04046963845773 7210932 7210932 H.E.L.P. ULTRAFILTER SMC 1.8 (US) B.BRAUN B.BRAUN AVITUM AG
28 04046963845766 7210931 7210931 H.E.L.P. PRECIPITATE FILTER (US) B.BRAUN B.BRAUN AVITUM AG
29 04046963711177 7210929 7210929 EMPTY BAG FOR PRIMING SOLUTION FUTURA US B.BRAUN B.BRAUN AVITUM AG
30 04046963711160 7210928 7210928 DIALYSING LINE FUTURA (US) B.BRAUN B.BRAUN AVITUM AG
31 04046963711153 7210927 7210927 ARTERIAL LINE FUTURA (US) B.BRAUN B.BRAUN AVITUM AG
32 04046963711139 7210925 7210925 H.E.L.P.® Plasmat® Futura Treatment Kit B.BRAUN B.BRAUN AVITUM AG